3TI1
CDK2 in complex with SUNITINIB
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | ROTATING ANODE |
Source details | RIGAKU MICROMAX-007 HF |
Temperature [K] | 93 |
Detector technology | CCD |
Collection date | 2011-05-06 |
Detector | RIGAKU SATURN 944+ |
Wavelength(s) | 1.54 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 53.560, 71.940, 72.460 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 18.779 - 1.990 |
Rwork | 0.205 |
R-free | 0.26210 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 1fin |
RMSD bond length | 0.008 |
RMSD bond angle | 1.222 |
Data reduction software | XDS |
Data scaling software | XDS |
Phasing software | PHENIX |
Refinement software | PHENIX ((phenix.refine: 1.7_650)) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 20.000 | 2.100 |
High resolution limit [Å] | 1.990 | 1.990 |
Rmerge | 0.077 | 0.382 |
Number of reflections | 19765 | |
<I/σ(I)> | 24.9 | 5.3 |
Completeness [%] | 99.8 | 100 |
Redundancy | 6.4 | 4.3 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 7.5 | 291 | 5 mg/mL CDK2 protein, 1.5 mM Sunitinib, 15% (v/v) PEG 3350, 50 mM HEPES/NaOH (pH 7.5), VAPOR DIFFUSION, HANGING DROP, temperature 291K |